Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2022. Start Trial.
Date Value
November 13, 2026 1.930
November 12, 2026 1.930
November 11, 2026 1.835
November 10, 2026 1.835
November 09, 2026 1.835
November 06, 2026 1.583
November 05, 2026 1.583
November 04, 2026 1.583
November 03, 2026 1.583
November 02, 2026 1.583
October 30, 2026 1.583
October 29, 2026 1.583
October 28, 2026 1.583
October 27, 2026 1.583
October 26, 2026 1.583
October 23, 2026 1.583
October 22, 2026 1.583
October 21, 2026 1.583
October 20, 2026 1.583
October 19, 2026 1.583
October 16, 2026 1.583
October 15, 2026 1.583
October 14, 2026 1.583
October 13, 2026 1.583
October 12, 2026 1.583
Date Value
October 09, 2026 1.583
October 08, 2026 1.583
October 07, 2026 1.479
October 06, 2026 1.479
October 05, 2026 1.479
October 02, 2026 1.479
October 01, 2026 1.479
September 30, 2026 1.479
September 29, 2026 1.545
September 28, 2026 1.545
September 25, 2026 1.545
September 24, 2026 1.545
September 23, 2026 1.545
September 22, 2026 1.545
September 21, 2026 1.545
September 18, 2026 1.545
September 17, 2026 1.545
September 16, 2026 1.545
September 15, 2026 1.545
September 14, 2026 1.639
September 11, 2026 1.584
September 10, 2026 1.338
September 09, 2026 1.338
September 08, 2026 1.338
September 04, 2026 1.338

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Novo Nordisk A/S 5.558
ALK-Abello A/S 7.627
AstraZeneca PLC 12.05
ANI Pharmaceuticals, Inc. 2.550
Corcept Therapeutics, Inc. 9.079

Price to Book Value Related Metrics